Viracta Therapeutics (VIRX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VIRX is expected to report earnings to fall 28.41% to -19 cents per share on March 18

Viracta Therapeutics VIRX Stock Earnings Reports

Q4'24

Est.

$-0.19

Q3'24

Est.

$-0.27

Q2'24

Beat

by $0.12

Q1'24

Beat

by $0.12

Q4'23

Missed

by $0.04

The last earnings report on November 13 showed earnings per share of -27 cents, meeting the estimate of -27 cents. With 16.35K shares outstanding, the current market capitalization sits at 8.57M.

View a ticker or compare two or three

Compare

VIRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VIRX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of oncology therapeutics for treatment of solid and hematologic cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2533 South Coast Highway 101

Phone

+1 858 400-8470

Employees

Web

https://www.viracta.com